Epithelial salivary gland tumours. An immunohistological and prognostic investigation.
Therkildsen
M H
MH
Department of Pathology, H:S Rigshospitalet, Denmark.
D000236:Adenoma / Q000737:chemistry / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D000911:Antibodies, Monoclonal / Q000276:immunology; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis* / Q000276:immunology; D002277:Carcinoma / Q000737:chemistry / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D002471:Cell Transformation, Neoplastic; D005260:Female; D005557:Formaldehyde; D006031:Glycosylation; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D009077:Mucins / Q000032:analysis; D016612:Paraffin Embedding; D011379:Prognosis; D011878:Radiotherapy; D012189:Retrospective Studies; D012468:Salivary Gland Neoplasms / Q000737:chemistry / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D012469:Salivary Glands / Q000737:chemistry; D016707:Tissue Fixation
D000911:Antibodies, Monoclonal; D015295:Antigens, Tumor-Associated, Carbohydrate; D009077:Mucins; C040286:Tn antigen; D005557:Formaldehyde